相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis
Dong Huang et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial
Carlo Salvarani et al.
JAMA INTERNAL MEDICINE (2021)
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Clark D. Russell et al.
LANCET (2020)
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
Eva Schrezenmeier et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study
N. Lian et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
Xiaolong Tian et al.
EMERGING MICROBES & INFECTIONS (2020)
Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
Zhen Zhu et al.
JOURNAL OF INFECTION (2020)
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Wei Tang et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients
Nan Wang et al.
CELL HOST & MICROBE (2020)
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19 A Randomized Clinical Trial
Ling Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection A Randomized Clinical Trial
Mayla Gabriela Silva Borba et al.
JAMA NETWORK OPEN (2020)
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
Maryam Edalatifard et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis
Jonathan A. C. Sterne et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
Christoph D. Spinner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Peter W. Horby et al.
LANCET (2020)
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study
Sean T. H. Liu et al.
NATURE MEDICINE (2020)
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Favipiravir versus other antiviral or standard of care for COVID-19 treatment: a rapid systematic review and meta-analysis
Dhan Bahadur Shrestha et al.
VIROLOGY JOURNAL (2020)
Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors
Nashwa Hafez Zaher et al.
ACTA PHARMACEUTICA (2020)
A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia
Yin Wang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Chemical synthesis, crystal structure, versatile evaluation of their biological activities and molecular simulations of novel pyrithiobac derivatives
Ren-Jun Wu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
Shuai Xia et al.
SCIENCE ADVANCES (2019)
Human Coronavirus: Host-Pathogen Interaction
To Sing Fung et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 73 (2019)
IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
Rudragouda Channappanavar et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Design, Synthesis, and Anti-RNA Virus Activity of 6′-Fluorinated-Aristeromycin Analogues
Ji-seong Yoon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors
Seri Jo et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63
Jing-Ru Weng et al.
VIRUS RESEARCH (2019)
Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes
Min-Han Lin et al.
ANTIVIRAL RESEARCH (2018)
Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses
Christin Mueller et al.
ANTIVIRAL RESEARCH (2018)
Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element
Anushka C. Galasiti Kankanamalage et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Peptide-Based Membrane Fusion Inhibitors Targeting HCoV-229E Spike Protein HR1 and HR2 Domains
Shuai Xia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient
Peihua Niu et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Beneficial effects of Houttuynia cordata polysaccharides on two-hit acute lung injury and endotoxic fever in rats associated with anti-complementary activities
Yan Lu et al.
ACTA PHARMACEUTICA SINICA B (2018)
Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents
Konstantina Karypidou et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
De Novo Design of α-Helical Lipopeptides Targeting Viral Fusion Proteins: A Promising Strategy for Relatively Broad-Spectrum Antiviral Drug Discovery
Chao Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Lisa E. Gralinski et al.
MBIO (2018)
Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset
Zhe Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility for structure-based drug design
Jozlyn R. Clasman et al.
SCIENTIFIC REPORTS (2017)
T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
William J. Liu et al.
ANTIVIRAL RESEARCH (2017)
Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor
Hiroyuki Konno et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CLPro inhibitors
Vathan Kumar et al.
ANTIVIRAL RESEARCH (2017)
Effective inhibition of MERS-CoV infection by resveratrol
Shih-Chao Lin et al.
BMC INFECTIOUS DISEASES (2017)
Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV
Ji-Young Park et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
Mizuki Yamamoto et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
Nan Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
Katherine V. Houser et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Coronaviruses - drug discovery and therapeutic options
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Shuo Su et al.
TRENDS IN MICROBIOLOGY (2016)
Tubulins interact with porcine and human S proteins of the genus Alphacoronavirus and support successful assembly and release of infectious viral particles
Anna-Theresa Ruediger et al.
VIROLOGY (2016)
3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012
Reed F. Johnson et al.
VIROLOGY (2016)
Antibody Response and Disease Severity in Healthcare Worker MERS Survivors
Abeer N. Alshukairi et al.
EMERGING INFECTIOUS DISEASES (2016)
Protease inhibitors targeting coronavirus and filovirus entry
Yanchen Zhou et al.
ANTIVIRAL RESEARCH (2015)
The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds
Yahira M. Baez-Santos et al.
ANTIVIRAL RESEARCH (2015)
Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus
Kai-Wen Cheng et al.
ANTIVIRAL RESEARCH (2015)
Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity
Hannah L. Peters et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection
Rudragouda Channappanavar et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Middle East Respiratory Syndrome Coronavirus nsp1 Inhibits Host Gene Expression by Selectively Targeting mRNAs Transcribed in the Nucleus while Sparing mRNAs of Cytoplasmic Origin
Kumari G. Lokugamage et al.
JOURNAL OF VIROLOGY (2015)
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
Davide Corti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
Kristen E. Pascal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis
Jie Zhou et al.
VIROLOGY JOURNAL (2015)
Design of Potential RNAi (miRNA and siRNA) Molecules for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Gene Silencing by Computational Method
Suza Mohammad Nur et al.
INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES (2015)
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
John Mair-Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
Adriaan H. de Wilde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Evaluation of SSYA10-001 as a Replication Inhibitor of Severe Acute Respiratory Syndrome, Mouse Hepatitis, and Middle East Respiratory Syndrome Coronaviruses
Adeyemi O. Adedeji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
Julie Dyall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Arbidol as a broad-spectrum antiviral: An update
Julie Blaising et al.
ANTIVIRAL RESEARCH (2014)
Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia
Dae Wook Kim et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2014)
Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease
Xingxing Yang et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays
Brit J. Hart et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Structural Basis for the Identification of the N-Terminal Domain of Coronavirus Nucleocapsid Protein as an Antiviral Target
Shing-Yen Lin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Adenosine Deaminase Acts as a Natural Antagonist for Dipeptidyl Peptidase 4-Mediated Entry of the Middle East Respiratory Syndrome Coronavirus
V. Stalin Raj et al.
JOURNAL OF VIROLOGY (2014)
Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies
Tianlei Ying et al.
JOURNAL OF VIROLOGY (2014)
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
Travis K. Warren et al.
NATURE (2014)
Rapid generation of a mouse model for Middle East respiratory syndrome
Jincun Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein
Liwei Jiang et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Coronavirus non-structural protein 16: Evasion, attenuation, and possible treatments
Vineet D. Menachery et al.
VIRUS RESEARCH (2014)
Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir
Javier Carbajo-Lozoya et al.
VIRUS RESEARCH (2014)
Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus
Anna Lundin et al.
PLOS PATHOGENS (2014)
Inhibition of Complement Activation Alleviates Acute Lung Injury Induced by Highly Pathogenic Avian Influenza H5N1 Virus Infection
Shihui Sun et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Dieckol, a SARS-CoV 3CLpro inhibitor, isolated, from the edible brown algae Ecklonia cava
Ji-Young Park et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment
Adriaan H. de Wilde et al.
JOURNAL OF GENERAL VIROLOGY (2013)
Inhibition of Middle East Respiratory Syndrome Coronavirus Infection by Anti-CD26 Monoclonal Antibody
Kei Ohnuma et al.
JOURNAL OF VIROLOGY (2013)
Structure of the Fusion Core and Inhibition of Fusion by a Heptad Repeat Peptide Derived from the S Protein of Middle East Respiratory Syndrome Coronavirus
Jing Gao et al.
JOURNAL OF VIROLOGY (2013)
The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists
Yang Yang et al.
PROTEIN & CELL (2013)
The newly emerged SARS-Like coronavirus HCoV-EMC also has an Achilles' heel: current effective inhibitor targeting a 3C-like protease
Zhilin Ren et al.
PROTEIN & CELL (2013)
Diarylheptanoids from Alnus japonica Inhibit Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus
Ji-Young Park et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
Ji-Young Park et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
A Human Coronavirus Responsible for the Common Cold Massively Kills Dendritic Cells but Not Monocytes
Mariana Mesel-Lemoine et al.
JOURNAL OF VIROLOGY (2012)
Severe Acute Respiratory Syndrome Coronavirus nsp1 Facilitates Efficient Propagation in Cells through a Specific Translational Shutoff of Host mRNA
Tomohisa Tanaka et al.
JOURNAL OF VIROLOGY (2012)
2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV)
Mi Kyoung Kim et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study
Fang Tang et al.
JOURNAL OF IMMUNOLOGY (2011)
Fully Human Monoclonal Antibody Directed to Proteolytic Cleavage Site in Severe Acute Respiratory Syndrome (SARS) Coronavirus S Protein Neutralizes the Virus in a Rhesus Macaque SARS Model
Tohru Miyoshi-Akiyama et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Broad-Spectrum Antiviral Therapeutics
Todd H. Rider et al.
PLOS ONE (2011)
The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
Susanne Pfefferle et al.
PLOS PATHOGENS (2011)
Literature-related discovery: Potential treatments and preventatives for SARS
Ronald N. Kostoff
TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE (2011)
SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii
Young Bae Ryu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Broad-Spectrum In Vitro Activity and In Vivo Efficacy of the Antiviral Protein Griffithsin against Emerging Viruses of the Family Coronaviridae
Barry R. O'Keefe et al.
JOURNAL OF VIROLOGY (2010)
A broad-spectrum antiviral targeting entry of enveloped viruses
Mike C. Wolf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Aryl diketoacids (ADK) selectively inhibit duplex DNA-unwinding activity of SARS coronavirus NTPase/helicase
Chaewoon Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Development of a Chimeric DNA-RNA Hammerhead Ribozyme Targeting SARS Virus
Akiko Fukushima et al.
INTERVIROLOGY (2009)
mRNA Display Design of Fibronectin-based Intrabodies That Detect and Inhibit Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein
Hsiang-I. Liao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3•TANK•TBK1/IKKε Complex
Kam-Leung Siu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Immunomodulatory and anti-SARS activities of Houttuynia cordata
Kit-Man Lau et al.
JOURNAL OF ETHNOPHARMACOLOGY (2008)
Antiviral effects of Glycyrrhiza species
Cristina Fiore et al.
PHYTOTHERAPY RESEARCH (2008)
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome
Mark J. Cameron et al.
JOURNAL OF VIROLOGY (2007)
Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S
Sara Akerstrom et al.
ANTIVIRAL RESEARCH (2007)
Studies on the interactions of Ti-containing polyoxometalates (POMs) with SARS-CoV 3CL(pro) by molecular modeling
Donghua Hu et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2007)
Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication
Lauren Wilson et al.
VIROLOGY (2006)
Human monoclonal antibody combination against SARS coronavirus: Synergy and coverage of escape mutants
Jan ter Meulen et al.
PLOS MEDICINE (2006)
Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor
Dong P. Han et al.
VIROLOGY (2006)
Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters
A Roberts et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Identification of natural compounds with antiviral activities against SARS-associated coronavirus
SY Li et al.
ANTIVIRAL RESEARCH (2005)
The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus
JA Tanner et al.
CHEMISTRY & BIOLOGY (2005)
Antiviral activity of glycyrrhizic acid derivatives against SARS - Coronavirus
G Hoever et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Inhibition of SARS-CoV replication by siRNA
CJ Wu et al.
ANTIVIRAL RESEARCH (2005)
Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference
YJ Zhang et al.
FEBS LETTERS (2004)
Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets
J ter Meulen et al.
LANCET (2004)
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
J Cinatl et al.
LANCET (2003)
Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area
CM Booth et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
分享论文
